Institutions | About Us | Help | Gaeilge
rian logo


Mark
Go Back
Global DNA methylation is altered by neoadjuvant chemoradiotherapy in rectal cancer and may predict response to treatment - A pilot study.
Tsang, J S; Vencken, S; Sharaf, O; Leen, E; Kay, E W; McNamara, D A; Deasy, J; Mulligan, E D
In rectal cancer, not all tumours display a response to neoadjuvant treatment. An accurate predictor of response does not exist to guide patient-specific treatment. DNA methylation is a distinctive molecular pathway in colorectal carcinogenesis. Whether DNA methylation is altered by neoadjuvant treatment and a potential response predictor is unknown. We aimed to determine whether DNA methylation is altered by neoadjuvant chemoradiotherapy (CRT) and to determine its role in predicting response to treatment.
Keyword(s): CANCER; MEDICAL TREATMENT
Publication Date:
2014
Type: Journal article
Peer-Reviewed: Unknown
Language(s): English
Contributor(s): Department of Surgical Research, Connolly Hospital & RCSI, Blanchardstown, Dublin, Ireland. Electronic address: julianst@yahoo.com.
Institution: Lenus
First Indexed: 2016-04-23 07:02:00 Last Updated: 2017-05-12 07:09:13